D-0391-2016 Class II Terminated

Recalled by Geritrex Corp — Mount Vernon, NY

FDA drug recall D-0391-2016 was initiated by Geritrex Corp on Oct 27, 2015 and is designated Class II. Reason for recall: Marketed without an Approved NDA/ANDA: FDA has determined that the products are unapproved new drugs and misbranded. The recall status is terminated (terminated Jun 11, 2018). Affected quantity: 1,032 tubes.

Recall details

Product Type
Drugs
Report Date
Dec 9, 2015
Initiation Date
Oct 27, 2015
Termination Date
Jun 11, 2018
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
1,032 tubes

Product description

Carbo-O-Philic 40 Gel 40% (Urea) NET WT tube, .5 oz (15 g), Rx Only For topical use only, Distributed byGeritrex Corporation 144, Mount Vernon, NY 10550, NDC 54162-016-15

Reason for recall

Marketed without an Approved NDA/ANDA: FDA has determined that the products are unapproved new drugs and misbranded.

Distribution pattern

Nationwide

Code information

Lot # 1502078, 1504139

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0391-2016
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0391-2016. Report a data issue: hello@regdatalab.com.